Stephen M. Prescott

Stephen M. Prescott's AcademicInfluence.com Rankings

Stephen M. Prescott

Philosophy

#5162

World Rank

#7894

Historical Rank

Logic

#2486

World Rank

#3486

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Stephen M. Prescott's Degrees

Bachelors Chemistry University of Washington
Masters Medicine University of Washington

Why Is Stephen M. Prescott Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stephen M. Prescott's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Rapid neutrophil adhesion to activated endothelium mediated by GMP-140 (1990) (1003)
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. (1995) (803)
Endothelial cell interactions with granulocytes: tethering and signaling molecules. (1992) (767)
Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. (1993) (740)
Platelet-activating factor. (1990) (730)
Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis (2001) (697)
Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils (1991) (633)
Activated platelets signal chemokine synthesis by human monocytes. (1996) (632)
Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils (1991) (626)
Anti-inflammatory properties of a platelet-activating factor acetylhydrolase (1995) (514)
Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer (2002) (488)
Platelet-activating factor and related lipid mediators. (2000) (484)
Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. (1996) (481)
Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. (1988) (435)
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. (1995) (425)
Intracellular unesterified arachidonic acid signals apoptosis. (2000) (419)
Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. (2001) (408)
Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. (1985) (407)
Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. (1984) (399)
Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion (1990) (394)
Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. (1995) (391)
Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. (1987) (376)
Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. (1985) (374)
The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis (2002) (357)
Inflammatory roles of P-selectin. (1993) (342)
Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. (1995) (312)
Peroxisome Proliferators Enhance Cyclooxygenase-2 Expression in Epithelial Cells* (1999) (309)
Post-transcriptional Control of Cyclooxygenase-2 Gene Expression (2000) (299)
Human plasma platelet-activating factor acetylhydrolase. Purification and properties. (1987) (298)
Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. (1998) (294)
Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates. (1991) (291)
Mammalian Diacylglycerol Kinases, a Family of Lipid Kinases with Signaling Functions* (1999) (286)
Cyclooxygenase-2 and carcinogenesis. (2000) (285)
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. (1996) (275)
Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. (1986) (268)
Platelet-activating Factor Acetylhydrolases* (1997) (268)
Oxidized Alkyl Phospholipids Are Specific, High Affinity Peroxisome Proliferator-activated Receptor γ Ligands and Agonists* (2001) (266)
Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate. (1983) (262)
Protein kinase C regulates the nuclear localization of diacylglycerol kinase-ζ (1998) (250)
Endothelial Cell Inflammatory Responses to Tumor Necrosis Factor α (1996) (249)
Platelet-activating factor: a phospholipid autacoid with diverse actions. (1993) (246)
Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2 (1996) (230)
Platelet-Activating Factor, a Pleiotrophic Mediator of Physiological and Pathological Processes (2003) (228)
The Leukocyte Integrins* (2000) (218)
An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. (1989) (217)
Plasma Platelet-activating Factor Acetylhydrolase Is a Secreted Phospholipase A2 with a Catalytic Triad (*) (1995) (217)
Human macrophages secret platelet-activating factor acetylhydrolase. (1990) (215)
Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. (1991) (215)
Release of Free F2-isoprostanes from Esterified Phospholipids Is Catalyzed by Intracellular and Plasma Platelet-activating Factor Acetylhydrolases* (2006) (214)
The effect of eicosapentaenoic acid on leukotriene B production by human neutrophils. (1984) (211)
Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. (2002) (211)
Discovery of an arachidonoyl coenzyme A synthetase in human platelets. (1982) (210)
Transforming Growth Factor-β1 Enhances Ha-ras-induced Expression of Cyclooxygenase-2 in Intestinal Epithelial Cells via Stabilization of mRNA* (2000) (208)
Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. (1997) (205)
Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. (1997) (202)
Regulation of Cyclooxygenase-2 Expression by the Translational Silencer TIA-1 (2003) (200)
Molecular Cloning of a Novel Human Diacylglycerol Kinase Highly Selective for Arachidonate-containing Substrates (*) (1996) (195)
Inflammatory Platelet-activating Factor-like Phospholipids in Oxidized Low Density Lipoproteins Are Fragmented Alkyl Phosphatidylcholines* (1999) (181)
Inherited predisposition to thrombosis (1993) (177)
Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. (1997) (174)
Activation of human neutrophil phospholipase D by three separable mechanisms (1990) (173)
Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans (2005) (169)
Molecular Cloning and Characterization of a Novel Human Diacylglycerol Kinase (*) (1996) (163)
Cell-cell interactions: leukocyte-endothelial interactions. (2003) (160)
Adhesion and signaling in vascular cell-cell interactions. (1996) (159)
Molecular Basis of the Interaction between Plasma Platelet-activating Factor Acetylhydrolase and Low Density Lipoprotein* (1999) (159)
Biologically Active Oxidized Phospholipids* (1999) (156)
Platelet‐activating factor: a mediator for clinicians (1995) (156)
The emerging roles of PAF acetylhydrolase This work was supported by National Institutes of Health Grants HL44513, HL35828, and HL087018. Published, JLR Papers in Press, October 6, 2008. (2009) (153)
Diacylglycerol kinase ɛ regulates seizure susceptibility and long-term potentiation through arachidonoyl– inositol lipid signaling (2001) (152)
Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. (1998) (150)
Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. (1989) (150)
Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. (1989) (146)
Activation of polymorphonuclear leukocytes reduces their adhesion to P-selectin and causes redistribution of ligands for P-selectin on their surfaces. (1995) (143)
Targeting of Diacylglycerol Degradation to M1 Muscarinic Receptors by ß-Arrestins (2007) (143)
Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. (2006) (140)
Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism. (1987) (138)
Novel leukocyte agonists are released by endothelial cells exposed to peroxide. (1992) (135)
The effects of mepacrine and p-bromophenacyl bromide on arachidonic acid release in human platelets. (1982) (130)
Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2. (2002) (130)
Shear stress activates cytosolic phospholipase A2 (cPLA2) and MAP kinase in human endothelial cells. (1996) (129)
Integrin-dependent Control of Translation: Engagement of Integrin αIIbβ3 Regulates Synthesis of Proteins in Activated Human Platelets (1999) (128)
The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C. (1989) (124)
Dipyridamole Selectively Inhibits Inflammatory Gene Expression in Platelet–Monocyte Aggregates (2005) (120)
Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. (1999) (119)
Cloning, expression, and chromosomal localization of human long-chain fatty acid-CoA ligase 4 (FACL4). (1998) (117)
Deep Venous Thrombosis of the Upper Extremity: A Reappraisal (1979) (115)
Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. (1987) (115)
Expression of Plasma Platelet-activating Factor Acetylhydrolase Is Transcriptionally Regulated by Mediators of Inflammation* (1998) (114)
Endothelial activation in ARDS. (1999) (113)
Outside-In Signals Delivered by Matrix Metalloproteinase-1 Regulate Platelet Function (2002) (113)
Oxidized LDL contains inflammatory PAF-like phospholipids. (2001) (113)
Diacylglycerol Kinase ζ Regulates Ras Activation by a Novel Mechanism (2001) (112)
Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. (2001) (112)
The necrotic venom of the brown recluse spider induces dysregulated endothelial cell-dependent neutrophil activation. Differential induction of GM-CSF, IL-8, and E-selectin expression. (1994) (112)
Production of platelet-activating factor by human vascular endothelial cells: evidence for a requirement for specific agonists and modulation by prostacyclin. (1985) (108)
Bioactive phospholipid oxidation products. (2000) (107)
Mammalian platelet-activating factor acetylhydrolases. (1996) (107)
The fatty acid composition of phosphatidylinositol from thrombin-stimulated human platelets. (1981) (105)
Differential Regulation of Matrix Metalloproteinase-9 by Monocytes Adherent to Collagen and Platelets (2001) (105)
The role of cyclooxygenase-2 and prostaglandins in colon cancer. (2007) (104)
Human endothelial cells synthesize ENA-78: relationship to IL-8 and to signaling of PMN adhesion. (1997) (104)
Is cyclooxygenase-2 the alpha and the omega in cancer? (2000) (104)
Interaction of γ1-Syntrophin with Diacylglycerol Kinase-ζ (2001) (98)
Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma. (1989) (97)
Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. (1997) (96)
The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein. (1992) (95)
Diacylglycerol kinases. (2004) (92)
Association of diacylglycerol kinase ζ with protein kinase C α (2003) (90)
P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes. (1995) (90)
Diacylglycerol kinase δ regulates protein kinase C and epidermal growth factor receptor signaling (2006) (89)
Platelet-activating factor acetylhydrolase from human plasma. (1990) (89)
Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase. (1991) (88)
Protein kinase C regulates the nuclear localization of diacylglycerol kinase-zeta. (1998) (82)
Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in human endothelial cells. (2000) (82)
Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes (2001) (81)
Juxtacrine intercellular signaling: another way to do it. (1993) (78)
Protein Kinase Cα Phosphorylates and Negatively Regulates Diacylglycerol Kinase ζ* (2003) (77)
Perspectives series: Cell adhesion in vascular biology. Adhesion and signaling in vascular cell-cell interactions (1996) (76)
Diacylglycerol kinase iota regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling. (2005) (74)
Expression of fatty acid‐CoA ligase 4 during development and in brain (2000) (74)
The Cloning and Characterization of a Novel Human Diacylglycerol Kinase, DGKι* (1998) (74)
Sol Sherry Lecture in Thrombosis: Molecular Events in Acute Inflammation (2002) (72)
Thrombin Stimulates Neutrophil Adherence by an Endothelial Cell‐Dependent Mechanism: Characterization of the Response and Relationship to Platelet‐Activating Factor Synthesis a (1986) (70)
Synthesis and release of platelet-activating factor by stimulated human mononuclear phagocytes. (1988) (70)
Monocyte Chemoattractant Protein-1 and 5-Lipoxygenase Products Recruit Leukocytes in Response to Platelet-Activating Factor-Like Lipids in Oxidized Low-Density Lipoprotein1 (2002) (70)
Platelet-activating factor (PAF): signalling and adhesion in cell-cell interactions. (1996) (69)
The Adenomatous Polyposis Coli Tumor Suppressor Gene Regulates Expression of Cyclooxygenase-2 by a Mechanism That Involves Retinoic Acid* (2006) (69)
Diacylglycerol kinase ζ regulates phosphatidylinositol 4-phosphate 5-kinase Iα by a novel mechanism (2004) (68)
The platelet-activating factor acetylhydrolase from human erythrocytes. Purification and properties. (1993) (67)
Celecoxib inhibits meningioma tumor growth in a mouse xenograft model (2007) (67)
Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. (2002) (67)
A novel syndrome of variant leukocyte adhesion deficiency involving defects in adhesion mediated by beta1 and beta2 integrins. (2001) (66)
Activation of vascular cells by PAF-like lipids in oxidized LDL. (2002) (65)
COX-2 and colorectal cancer. (2003) (64)
Endothelium from Diverse Vascular Sources Synthesizes Platelet‐Activating Factor (1988) (64)
Human endothelial cells regulate polymorphonuclear leukocyte degranulation (1998) (62)
EXOGENOUS PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE REDUCES MORTALITY IN MICE WITH SYSTEMIC INFLAMMATORY RESPONSE SYNDROME AND SEPSIS (2006) (61)
Monocyte Tethering by P-Selectin Regulates Monocyte Chemotactic Protein-1 and Tumor Necrosis Factor-a Secretion Signal Integration and NF-cB Translocation (59)
Synaptic removal of diacylglycerol by DGKζ and PSD‐95 regulates dendritic spine maintenance (2009) (59)
Three secretory phospholipase A(2) genes that map to human chromosome 1P35-36 are not mutated in individuals with attenuated adenomatous polyposis coli. (1996) (58)
Endothelial cells for studies of platelet-activating factor and arachidonate metabolites. (1990) (56)
Controversies in COX-2 selective inhibition. (2002) (55)
The interaction of leukocytes with platelets in blood coagulation (1995) (54)
Alternative splicing of the human diacylglycerol kinase ζ gene in muscle (1997) (54)
Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. (2001) (54)
Lipid metabolism and signal transduction in endothelial cells. (1990) (54)
The p38 MAPK Pathway Mediates Transcriptional Activation of the Plasma Platelet-activating Factor Acetylhydrolase Gene in Macrophages Stimulated with Lipopolysaccharide* (2004) (53)
P-selectin is acylated with palmitic acid and stearic acid at cysteine 766 through a thioester linkage. (1993) (52)
The effects of a diet rich in fish oil on human neutrophils: identification of leukotriene B5 as a metabolite. (1985) (52)
Leukotriene B formation by neutrophils from essential fatty acid-deficient rats. (1984) (51)
The Role of Platelet-Activating Factor in Endothelial Cells (1990) (51)
Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. (1995) (51)
Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase. (2005) (50)
DGKι regulates presynaptic release during mGluR‐dependent LTD (2011) (50)
Venous thromboembolism in decompensated chronic obstructive pulmonary disease. A prospective study. (2015) (46)
Phospholipid remodeling in human neutrophils. Parallel activation of a deacylation/reacylation cycle and platelet-activating factor synthesis. (1989) (45)
Interaction of gamma 1-syntrophin with diacylglycerol kinase-zeta. Regulation of nuclear localization by PDZ interactions. (2001) (44)
Synthesis of platelet-activating factor by endothelial cells. The role of G proteins. (1990) (44)
Culture of mesothelial cells from bovine pericardium and characterization of their arachidonate metabolism. (1987) (44)
Adhesion and signaling in vascular cell--cell interactions. (1996) (43)
Analysis of oxidized glycerophosphocholine lipids using electrospray ionization mass spectrometry and microderivatization techniques. (2000) (42)
Protein kinase C alpha phosphorylates and negatively regulates diacylglycerol kinase zeta. (2003) (42)
Diacylglycerol kinase delta regulates protein kinase C and epidermal growth factor receptor signaling. (2006) (41)
Oxidatively fragmented phospholipids as inflammatory mediators: the dark side of polyunsaturated lipids. (1995) (41)
Regulation of COX-2 transcription in a colon cancer cell line by Pontin52/TIP49a (2003) (41)
Association of diacylglycerol kinase zeta with protein kinase C alpha: spatial regulation of diacylglycerol signaling. (2003) (40)
Proliferation-dependent changes in release of arachidonic acid from endothelial cells. (1994) (40)
CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes. (1994) (40)
Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression. (2009) (39)
The Scent of a Phagocyte (2000) (38)
Synergism Between Platelet-Activating Factor-Like Phospholipids and Peroxisome Proliferator-Activated Receptor γ Agonists Generated During Low Density Lipoprotein Oxidation That Induces Lipid Body Formation in Leukocytes1 (2003) (38)
Molecular basis for susceptibility of plasma platelet‐activating factor acetylhydrolase to oxidative inactivation (2007) (37)
Molecular cloning and characterization of a novel human diacylglycerol kinase zeta. (1996) (37)
Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. (2005) (37)
Coengagement of ICAM-3 and Fc receptors induces chemokine secretion and spreading by myeloid leukocytes. (1998) (36)
IFN-ε Mediates TNF-α-Induced STAT1 Phosphorylation and Induction of Retinoic Acid-Inducible Gene-I in Human Cervical Cancer Cells1 (2007) (35)
Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. (1992) (35)
Diacylglycerol Kinases: Regulation and Signaling Roles (2002) (33)
Leucocyte-endothelial cell interactions (1992) (32)
Platelet-activating factor acetylhydrolase in human erythrocytes. (1991) (32)
"Pseudo-pseudothrombophlebitis": ruptured popliteal cyst with deep venous thrombosis. (1978) (32)
Fish oil fix (2005) (31)
Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver. (2001) (31)
Activation of the acetyl-coenzyme A:lysoplatelet-activating factor acetyltransferase regulates platelet-activating factor synthesis in human endothelial cells. (1992) (30)
Bacterial Clearance Is Improved in Septic Mice by Platelet-Activating Factor-Acetylhydrolase (PAF-AH) Administration (2013) (30)
IFN-epsilon mediates TNF-alpha-induced STAT1 phosphorylation and induction of retinoic acid-inducible gene-I in human cervical cancer cells. (2007) (29)
RHC 80267 does not inhibit the diglyceride lipase pathway in intact platelets. (1983) (29)
Dermatitis induced by warfarin. (1978) (29)
Diacylglycerol kinase zeta regulates phosphatidylinositol 4-phosphate 5-kinase Ialpha by a novel mechanism. (2004) (28)
Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury. (1999) (28)
Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes. (1994) (28)
Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme. (2007) (28)
Hirudin-based peptides block the inflammatory effects of thrombin on endothelial cells. (1990) (27)
Production of platelet-activating factor by endothelial cells. (1987) (26)
The cloning and developmental regulation of murine diacylglycerol kinase ζ (1998) (25)
Retinoic acid inhibits beta-catenin through suppression of Cox-2: a role for truncated adenomatous polyposis coli. (2007) (25)
Arachidonate Metabolism in Cultured Fibroblasts Derived From Normal and Infarcted Canine Heart (1989) (24)
Production of platelet-activating factor, a biologically active lipid, by vascular endothelial cells. (1987) (24)
Bacterial lipopolysaccharide induces endothelial cells to synthesize a degranulating factor for neutrophils (1998) (23)
Growth-dependent changes in arachidonic acid release from endothelial cells are mediated by protein kinase C and changes in diacylglycerol. (1993) (23)
Characterization and assay of diacylglycerol lipase from human platelets. (1982) (23)
Development and characterization of a tissue culture cell line with essential fatty acid deficiency. (1982) (22)
Integrin αDβ2 Is Dynamically Expressed by Inflamed Macrophages and Alters the Natural History of Lethal Systemic Infections1 (2008) (20)
Can licorice lick colon cancer? (2009) (20)
The inducible prostaglandin biosynthetic enzyme, cyclooxygenase 2, is not mutated in patients with attenuated adenomatous polyposis coli. (1998) (20)
The cloning and characterization of a novel human diacylglycerol kinase, DGKiota. (1998) (20)
A Thematic Series on Phospholipases* (1997) (20)
Inflammation as an early component of atherosclerosis and vascular damage--a role for P-selectin and platelet-activating factor. (1996) (19)
The Production of Platelet-Activating Factor by Cultured Human Endothelial Cells: Regulation and Function (1987) (19)
Regulation of platelet-activating factor (PAF) synthesis and PAF-mediated neutrophil adhesion to endothelial cells activated by thrombin. (1992) (18)
Leukotriene B4 is an incomplete agonist for the activation of human neutrophils. (1984) (18)
Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages. (2003) (17)
Brief review: molecular mechanisms of neutrophil binding to endothelium involving platelet-activating factor and cytokines. (1990) (16)
Integrin alphaDbeta2 is dynamically expressed by inflamed macrophages and alters the natural history of lethal systemic infections. (2008) (16)
Uptake and release of arachidonate by platelets. (1983) (14)
Classification of venous thromboembolism (VTE) (2005) (14)
Platelet-Activating Factor and PAF-Like Mimetics (1996) (13)
Regulates Ras Activation by a Novel Mechanism (2001) (13)
The COXes of Danio: From mechanistic model to experimental therapeutics (2002) (13)
Endothelial cells reestablish functional integrity after reversible permeabilization. (1991) (13)
Mechanisms of vascular injury in the pathogenesis of infectious disease (1992) (12)
The plasma PAF acetylhydrolase prevents oxidative modification of low density lipoprotein (1994) (12)
Lung production of platelet-activating factor acetylhydrolase in oleic acid-induced acute lung injury. (2007) (12)
Platelet‐activating factor: antagonists, terminators, molecular mimics, and microbial opportunism (1996) (11)
Alternative splicing of the human diacylglycerol kinase zeta gene in muscle. (1997) (10)
Protein kinase C regulates the synthesis of platelet-activating factor by human monocytes. (1991) (10)
131I-labeled fibrinogen in the diagnosis of deep vein thrombosis of the lower extremities. (1978) (10)
Platelet-activating factor acetylhydrolase activity in human tissues and blood cells (1991) (10)
Oxidized phospholipids with PAF-like bioactivity (1994) (9)
A Thematic Series on Kinases and Phosphatases That Regulate Lipid Signaling* (1999) (8)
Inflammation in the vascular wall as an early event in atherosclerosis (1997) (8)
The regulation of synthesis of platelet-activating factor by endothelial cells. (1988) (8)
Events at the Vascular Wall (2001) (8)
Platelet Signal-Dependent Protein Synthesis (2005) (8)
Functional and structural features of plasma platelet-activating factor acetylhydrolase. (1996) (8)
Platelet-activating factor and related lipid mediators 2 : roles in health and disease (1996) (7)
New roles for an old drug: inhibition of gene expression by dipyridamole in platelet-leukocyte aggregates. (2006) (7)
Platelet-activating factor: A signaling molecule for leukocyte adhesion (1999) (7)
Characterization of the human diacylglycerol kinase ε gene and its assessment as a candidate for inherited retinitis pigmentosa (1999) (7)
Cardiovascular effects of platelet-activating factor. (1991) (6)
Characterization of human UMP-CMP kinase enzymatic activity and 5' untranslated region. (2001) (6)
The fate of platelet-activating factor: PAF acetylhydrolases from plasma and tissues (1996) (5)
DNase I treatment of total RNA improves the accuracy of ribonuclease protection assay. (1998) (5)
Evaluation of human diacylglycerol kinase(iota), DGKI, a homolog of Drosophila rdgA, in inherited retinopathy mapping to 7q. (2000) (5)
Chapter 145 – Diacylglycerol Kinases (2010) (4)
Molecular Cloning and Characterization of a Novel Human Diacylglycerol Kinase (cid:122) * (1996) (4)
Platelet-activating factor: New roles in cell-cell interactions (1994) (4)
Prostaglandins and Related Compounds Lipid Messengers with Many Actions (1996) (4)
Classification of venous thromboembolism (VTE). The clot is hot: inflammation, myeloid leukocytes, and venous thromboembolism. (2005) (4)
Novel Neutrophil Agonists: Oxidatively-Fragmented Phosphatidylcholines (1991) (4)
Inflammatory actions of platelet-activating factor: control by PAF acetylhydrolase. (1997) (3)
A Thematic Series on Oxidation of Lipids as a Source of Messengers* (1999) (3)
Naturally Occurring Lipids Influence the Interaction of Human Endothelial Cells and Neutrophils1 (1987) (3)
Human macrophages secrete platelet-activating factor acetylhydrolase. A mechanism for resolution of pulmonary inflammation. (1991) (3)
Characterization of the human diacylglycerol kinase epsilon gene and its assessment as a candidate for inherited retinitis pigmentosa. (1999) (2)
Interaction of g1-Syntrophin with Diacylglycerol Kinase-z (2001) (2)
Molecular Mechanisms of Juxtacrine Cell Signalling in Microvascular Responses and Inflammation (2003) (2)
to Human Endothelial Cells In Vitro (1985) (2)
Retinoic Acid Inhibits β-Catenin through Suppression of Cox-2 (2007) (2)
Purification of human plasma platelet-activating factor acetylhydrolase (1986) (2)
Review article Diacylglycerol kinases (2004) (1)
Oxidized Phospholipids as Mediators of Vascular Disease (2000) (1)
Effect of Platelet Activating Factor-Acetyihydrolase on the Formation and Action of Minimally Oxidized Low Density Lipoprotein (2013) (1)
Engagement of Intercellular Adhesion Molecule 3 (ICAM-3) Induces Proinflammatory Chemokine Secretion by Myeloid Leukocytes • 1284 (1997) (1)
Thrombosis Molecular Events in Acute Inflammation (2002) (1)
What are the effects of dietary fatty acid modification on platelet eicosanoid metabolism, platelet-activating factor, and platelet function? How might these metabolic alterations influence thrombosis? (1992) (1)
Signaling in the Vascular Play Book Platelets, Endothelial Cells, Inflammatory Chemokines, and Restenosis : Complex (2012) (1)
Selective hydrolosis of oxidatively-fragmented phospholipids by the PAF acetylhydrolase (1990) (1)
Diacylglycerol Kinase Epsilon Gene Specifically Modulates Morphology and Survival in ARPE-19 Cells (2002) (0)
Metabolism of platelet activating factor in human blood (1986) (0)
Hemodynamics for hematologists. (1979) (0)
Lipids in Oxidized Low-Density Lipoprotein in Response to Platelet-Activating Factor-Like 5-Lipoxygenase Products Recruit Leukocytes (2002) (0)
An alternative splicing form of dgkδ in muscle cells (1996) (0)
Cloning, expression, and chromosomal localization of human arachidonic acid-preferring acyl coa synthetase (1998) (0)
Developmental regulation of diacylglycerol kinase ξ (1997) (0)
CHAPTER 162 – Diacylglycerol Kinases (2003) (0)
Arachidonic acid metabolism in fibroblasts derived from canine myocardium (1986) (0)
Arachidonate Metabolism in Cultured Bovine Pericardial Mesothelial Cells with Special Reference to Prostacyclin Production in Response to Thrombin, Histamine and Bradykinin: ―Prostaglandin I 2 産生を中心に― (1986) (0)
The Role of Prostaglandins in the Growth of Breast Epithelial Cells. (1995) (0)
Lipid Second Messengers (1996) (0)
Molecular cloning and characterization of a novel human diacyglycerol kinase 5 containing ankyrin repeats (1996) (0)
P4-076 Polymorphism in the cyclooxygenase-2 (COX-2) and presenilin 2 (PS2) gene promoters: impact on inflammatory signaling and potential contribution to the etiopathology of Alzheimer's disease (AD) (2004) (0)
Oxidatively-fragmented phosphatidylcholine activates human neutrophils: The role of the receptor for platelet-activating factor (PAF) (1990) (0)
Molecular cloning of human endothelial cell type II prostaglandin endoperoxide synthase and demonstration of expression in response to cytokines (1992) (0)
Inhibition of Platelet-activating Factor Acetylhydrolase Activity by Oxidants. † 1541 (1997) (0)
Platelet-Activating Factor Regulates Events at the Vascular Wall (1996) (0)
Purification of Platelet-Activating Factor Acetylhydrolase (1986) (0)
Defective control of protein synthesis in colon cancer cells results in constitutive expression of cyclooxygenase-2 protein* (1998) (0)
CHARACfERIZATION OF INTERACITONS BE1WEEN NEUROTENSIN AND DOPAMINE SYSTEMS IN THE RAT BRAIN by (2012) (0)
The association of paf acetylhydrolase with ldl involves n-terminal domains in the enzyme and c-terminal domains in apolipoprotein B (1996) (0)
Oxygen metabolites and vascular damage (2016) (0)
Type 2 Expression by Human Neutrophils Inflammatory Agonists Induce Cyclooxygenase (1998) (0)
Factor Acetylhydrolases Intracellular and Plasma Platelet-activating Esterified Phospholipids Is Catalyzed by -isoprostanes from 2 Release of Free F (2014) (0)
Molecules Required for Activated Platelets to Adhere to and Signal Human Monocytes (2002) (0)
Diacylglycerol kinase (cid:1) regulates protein kinase C and epidermal growth factor receptor signaling (2006) (0)
Acid-Inducible Gene-I in Human Cervical Phosphorylation and Induction of Retinoic -Induced STAT1 α Mediates TNF- ε IFN- (2014) (0)
Platelet activating factor in the vascular system: prototype of an inflammatory autacoid (1992) (0)
PAF and Related Lipids Regulate Events in the Vascular Wall (1993) (0)
Cancer Cells Acid-Inducible Gene-I in Human Cervical Phosphorylation and Induction of Retinoic-Induced STAT 1 α Mediates TNF-ε IFN-Stafforini (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stephen M. Prescott?

Stephen M. Prescott is affiliated with the following schools: